Tang Capital Acquisition, a blank check company targeting development-stage biopharma companies, filed on Tuesday with the ...

Allarity Acquisition, a blank check company backed by Allarity Therapeutics targeting life sciences and biotech, lowered the ...

TRex Bio, a Phase 1 biotech developing medicines for autoimmune and inflammatory diseases, announced terms for its IPO on ...

Retension Pharmaceuticals, a Phase 2b biotech developing an in-licensed treatment for hypertension, announced terms for its ...

Smart ring maker Oura (OURA) postponed its $2.1 billion IPO, which was scheduled to begin trading on Wednesday. The company stated in a press release that, despite strong demand, it was postponing due ...

Pop Global Acquisition, a blank check company targeting advanced software, hardware, materials and energy technologies, filed ...

Big Development: London's quiet IPO market is teeing up for its biggest listing in over five years, as Africa-focused fintech ...

Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses what Oura's ...

Two sizable IPOs are scheduled for the week ahead. VC-backed smart ring maker Oura plans the largest consumer discretionary IPO in years, while PE-backed Accelevation sill serve as a key test for the ...

Southport Acquisition II, a blank check company led by TVC Capital's Jeb Spencer targeting the AI industry, raised $200 ...

Oura, which sells smart rings and subscriptions for personalized health insights, postponed its IPO on Tuesday.

One IPO and two SPACs debuted this week, although more deals were originally on the calendar. Five IPOs and three SPACs submitted initial filings. The biggest story in the IPO market this week may be ...